The Clorox Company filed Definitive Additional Materials (DEFA14A) on October 29, 2026, supplementing its 2026 Annual Meeting proxy statement to disclose the appointment of Fabian Garcia as Chief Executive Officer effective January 5, 2027, and the planned board leadership changes accompanying his arrival.

Key Highlights

  • New CEO named: Fabian Garcia, age 66, will become Chief Executive Officer of The Clorox Company effective January 5, 2027, as disclosed in the filing.
  • Predecessor transition: Linda Rendle will step down as CEO and as a director on that date and will serve as a senior advisor through April 2, 2027, according to the filing.
  • Board chair change: Matthew J. Shattock, currently Lead Independent Director, will become Independent Chair and will receive an Independent Chair retainer of $225,000 in addition to his existing director compensation.
  • Base salary and bonus: Garcia's offer letter sets an annual base salary of $100,000 and a target annual bonus opportunity of $2,000,000, settled in shares of Company common stock.
  • Long-term incentive: Garcia is eligible for a pro-rated long-term incentive award with a target value of $4,550,000 for fiscal year 2027, comprised of 60% performance share units and 40% RSUs; beginning September 2027 the annual target rises to $9,100,000.
  • Prior experience: Garcia has served as Business Group President, Personal Care at Unilever PLC since 2022 and previously served as CEO of Revlon, Inc. from 2016 to 2018.
  • Earnings timing: According to the filing, Clorox is scheduled to report first quarter fiscal year 2027 earnings on November 2, with Rendle and Chief Financial Officer Luc Bellet participating in the analyst call.

Garcia's Background and Compensation Terms at NYSE:CLX

According to the filing, The Clorox Company (NYSE:CLX) filed supplemental proxy materials disclosing that its Board of Directors appointed Fabian Garcia as CEO on October 28, 2026, with an effective date of January 5, 2027. Clorox, headquartered in Oakland, California since 1913, markets a portfolio of consumer brands including Brita, Burt's Bees, Clorox, Fresh Step, Glad, Hidden Valley, Kingsford, Liquid-Plumr, Pine-Sol, and Purell, among others. The company said the appointment followed "a comprehensive search."

The filing states that Garcia, age 66, has served as Business Group President, Personal Care at Unilever PLC since 2022. He joined Unilever in 2020 as President of Unilever North America. Before Unilever, he was CEO of Revlon, Inc. from 2016 to 2018, and held various positions at Colgate-Palmolive from 2003 to 2016, including Chief Operating Officer, Global Innovation and Growth. Earlier in his career, he held global leadership roles at Procter and Gamble. He currently serves on the Board of Directors of Wells Fargo and previously served on the boards of Kimberly-Clark and Arrow Electronics.

Under the offer letter dated October 27, 2026, Garcia's annual base salary is set at $100,000. His target annual bonus opportunity is $2,000,000, settled in shares of Company common stock and prorated for fiscal year 2027. The pro-rated long-term incentive award for the current fiscal year carries a target value of $4,550,000, split 60% in performance share units vesting after the fiscal 2027-2029 performance period and 40% in RSUs vesting ratably over four years, each subject to continued employment and the terms of the applicable award agreement. Beginning in September 2027, the target annual long-term incentive award value rises to $9,100,000, according to the filing. The filing also notes that Garcia has no familial relationships or related party transactions with the Company requiring disclosure under Items 401(d) or 404(a) of Regulation S-K.

What Was Disclosed

The DEFA14A supplement filed October 29, 2026, disclosed Garcia's appointment as CEO effective January 5, 2027, Rendle's planned advisory role through April 2, 2027, Shattock's transition to Independent Chair with a $225,000 retainer, and the key terms of Garcia's compensation offer letter.